Pacer Advisors’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$264K Sell
8,199
-2,081
-20% -$77K ﹤0.01% 1675
2025
Q4
$433K Buy
10,280
+7,156
+229% +$288K ﹤0.01% 1821
2025
Q3
$107K Buy
+3,124
New +$89.6K ﹤0.01% 2247
2024
Q3
Sell
-626
Closed -$13.6K 2703
2024
Q2
$13.6K Sell
626
-811
-56% -$17.1K ﹤0.01% 3501
2024
Q1
$31.8K Buy
+1,437
New +$35.1K ﹤0.01% 3341
2021
Q2
Sell
-1,488
Closed -$80K 1562
2021
Q1
$80K Sell
1,488
-720
-33% -$41.5K ﹤0.01% 1322
2020
Q4
$108K Sell
2,208
-172
-7% -$7.97K ﹤0.01% 1357
2020
Q3
$77K Buy
+2,380
New +$75.6K ﹤0.01% 1282

Other funds holding VCYT

Pacer Advisors's VCYT Position: Q1 2026 in Review

Pacer Advisors reduced its Veracyte (VCYT) stake by 20% in Q1 2026, selling an estimated $77K and leaving 8,199 shares worth $264K. The position accounts for ﹤0.01% of the portfolio, ranked #1675.

Pacer Advisors first reported a position in VCYT in Q3 2020 and has held it in 8 quarters since. The position peaked at $433K in Q4 2025. 334 funds tracked by Wall St. Rank hold VCYT as of Q1 2026.

  • Pacer Advisors held 8,199 shares of Veracyte worth $264K as of Q1 2026.
  • Pacer Advisors sold 2,081 Veracyte shares in Q1 2026, an estimated $77K.
  • Veracyte made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1675 holding.
  • Pacer Advisors first reported a position in Veracyte in Q3 2020 and has held it in 8 quarters since.
  • Pacer Advisors's Veracyte position peaked at $433K in Q4 2025.
  • 334 funds tracked by Wall St. Rank held Veracyte as of Q1 2026.

Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.